Internal Server Error

Optimal Tracers - About the company

Optimal Tracers is an acquired company based in Sacramento (United States), founded in 2013. It operates as a CRO focused on clinical research and tracer development services. The company has 8 active competitors, including 2 funded and 2 that have exited. Its top competitors include companies like Lexitas, Eyecro and Humonix Biosciences.

Company Details

Social
Facebook
Phone Number
+1 **********
Part Of
Key Metrics
Founded Year
2013
Location
Sacramento, United States
Stage
Acquired
Ranked
Employee Count
3 as on Apr 30, 2026
Similar Companies
Exit Details
Acquired by Telix Pharma (Nov 13, 2022)

Optimal Tracers's acquisition details

Optimal Tracers got acquired by Telix Pharma on Nov 13, 2022.
Click here to take a look at Optimal Tracers's acquisition in detail
Sign up to download Optimal Tracers' company profile

Optimal Tracers's funding and investors

Optimal Tracers has not raised any funding rounds yet.

Optimal Tracers' founders and board of directors

Founder? Claim Profile

Optimal Tracers' employee count trend

Optimal Tracers has 3 employees as of Apr 26. Here is Optimal Tracers's employee count trend over the years:
Employee count trend for Optimal Tracers
lockUncover Optimal Tracers' growth story! Sign up today!
chrome_extension_cta_illustration
Access Tracxn on any website
Our Google Chrome extension lets you view company details while browsing their websites
Install Tracxn Extension

Optimal Tracers's Competitors and alternates

Top competitors of Optimal Tracers include Lexitas, Eyecro and Humonix Biosciences. Here is the list of Top 10 competitors of Optimal Tracers, ranked by Tracxn score:
Rank
Company Details
Short Description
Total Funding
Investors
Tracxn Score
1st
Logo for Lexitas
Lexitas
2011, Durham (United States), Acquired
Provider of clinical trial and medical strategy services for developing ophthalmology products
-
-
46/100
2nd
Logo for Eyecro
Eyecro
2005, Oklahoma City (United States), Funding Raised
Preclinical ophthalmic research leader, specializing in novel test agents and therapeutic modalities
-
 
35/100
3rd
CRO focused on ophthalmic drugs development services
$250K
29/100
4th
Logo for Experimentica
Experimentica
2013, Kuopio (Finland), Funding Raised
Developing in vitro, ex vivo and in vivo preclinical ocular models
-
28/100
5th
Logo for Optimal Tracers
Optimal Tracers
2013, Sacramento (United States), Acquired
CRO focused on clinical research and tracer development services
-
-
23/100
6th
Logo for Aufbau Holdings
Aufbau Holdings
2019, Dublin (Ireland), Series A
Developer of diagnostic and therapeutic platforms for cancer and eye diseases
$6.1M
-
22/100
7th
Logo for Rudacure
Rudacure
2018, Incheon (South Korea), Unfunded
Developer of Rac1 inhibitors for treating ocular surface diseases
-
-
18/100
8th
Logo for VO-CRO
VO-CRO
1995, Nashville (United States), Unfunded
CRO focused on preclinical studies of ophthalmic diseases
-
-
18/100
9th
Logo for Ophthy-DS
Ophthy-DS
2009, Michigan City (United States), Deadpooled
Provider of preclinical services for drug development
-
-
17/100
10th
Logo for ImmunEyez
ImmunEyez
2015, Georgetown (United States), Deadpooled
Provider of preclinical research services
-
-
16/100
lockGet insights and benchmarks for competitors of 2M+ companies! Sign up today!
Looking for more details on Optimal Tracers's competitors? Click here to see the top ones

Optimal Tracers's Investments and acquisitions

Optimal Tracers has made no investments or acquisitions yet.

News related to Optimal Tracers

lockGet curated news about company updates, funding rounds, M&A deals and others. Sign up today!

FAQs about Optimal Tracers

Explore our recently published companies
Tracxn powers 1,000+ customers across 30+ countries
Accel PartnersPartechIN-Q-TEL - USFujitsuTenityStanford